Brought to you by 
Variagenics raises $19mm in private placement
17 Mar 2000
Executive Summary
Variagenics (pharmacogenomics) raised $19mm in a private placement led by The Sprout Group. Existing investors Atlas Venture, Oxford Bioscience Partners, Forward Ventures, Kummell Investments, Goldman Sachs, and Advent International also participated along with new investor AM Pappas. The Sprout Group's Philippe Chambon will join the company's board.
Deal Industry
- Pharmaceuticals
- Research, Analytical Equipment & Supplies
-
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
-
Biotechnology
- Pharmacogenetics-Pharmacogenomics
-
Drug Discovery Tools
- Genomics-Proteomics
Deal Status
- Final
Deal Type
-
Financing
- Private Placement
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Variagenics raises $19mm in private placement
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice